查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363377

研究級蛋白質市場規模、佔有率和趨勢分析報告：按產品、按宿主細胞、按最終用途、按地區、按細分市場、預測，2023-2030 年

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies), By Host Cell (Mammalian Cells, Bacterial Cells), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

研究級蛋白質市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球研究級蛋白質市場規模將達到26.9億美元，2023年至2030年年複合成長率為15.53%。

癌症研究領域研發投資的增加和個體化藥物需求的增加預計將有助於市場成長。此外，許多國家的政府對各種臨床研究的投資正在增加，預計這將推動市場成長。此外，新興國家生物技術產業的不斷進步進一步推動了預測期內的市場成長。

由於疫苗、診斷和治療方法開發的研究活動激增，COVID-19 大流行對市場產生了積極影響。隨著法規專注於加快候選疫苗的核准流程，對合約製造的需求增加。儘管 mRNA 疫苗等新型疫苗平台受到了廣泛關注，但重組蛋白疫苗的幾種替代也在評估中。例如，2022 年 7 月，Novavax 的 COVID-19 疫苗 (NVX-CoV2373) 獲得了在歐盟使用的延長有條件行銷核准。此外，疫情凸顯了生技藥品對敏捷、靈活的製造能力的需求。預計這一要素將在不久的將來增強競爭形勢並推動市場成長。

據 Global Genes 稱，截至 2019 年 10 月，全球有超過 4 億人患有罕見或遺傳性疾病。這個數字表明迫切需要健康意識以及治療方法和臨床環境的改進。對藥物標靶機制的先進研究和知識的需求對於藥物開發至關重要。在許多地區，隊列計劃透過開發生物庫並為研究人員提供高品質樣本，徹底改變了治療配合措施。因此，預計對各種疾病的生物標記的研究將受到更多關注。因此，研究配合措施和政府對建立更好的醫療基礎設施的興趣預計將增強研究級蛋白質的應用，從而推動市場成長。

然而，蛋白質生產是一個耗時的過程，而這個過程往往需要對工作條件進行高度維護和管理。儘管對這些重組產品的需求很高且不斷成長，但法規機構的支持仍然進展緩慢。研究級蛋白質通常透過宿主或表現系統產生，其中透過轉染、細菌轉化或病毒導入階段來表達目標產物的特異性基因。這個複雜的過程常常會受到非目標區域過度表現的影響，而且也很耗時。因此，缺乏有關重組技術的具體指南和法規是阻礙研究級蛋白質市場繁榮的主要要素。

研究級蛋白質市場報告亮點

  • 按產品，細胞激素和生長因子領域市場佔據市場主導地位，2022 年收益佔有率最高，為 23.36%，預計該領域在預測期內將以 17.62% 的最快年複合成長率成長。這是由於它在藥物研發和藥物開發的各種臨床試驗中的作用。
  • 從宿主細胞來看，哺乳動物細胞細分市場佔主導地位，2022年收益佔有率最高，達55.73%。如此大的佔有率主要是由於其生物結構與人類細胞相似，可用於生產單株抗體和疫苗等生物製藥。
  • 依最終用途，製藥和生技公司佔最大佔有率，2022年將達61.35%。由於藥物研發發現和開發的研究活動增加以及對個體化藥物的需求增加，預計在預測期內對研究級蛋白質的需求將增加。
  • 按地區分類，北美佔據市場主導地位，2022 年銷售額佔有率為 44.86%。這一巨大佔有率歸因於主要市場參與者和強大的醫療基礎設施的存在。預計這些要素將在預測期內推動該地區的研究級蛋白質市場。

目錄

第1章 研究級蛋白質市場：調查方法與範圍

第2章 研究級蛋白質市場：執行摘要

  • 市場概述
  • 分段簡介
  • 競爭形勢概覽

第3章 研究級蛋白質市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場趨勢及展望
  • 市場動態
    • 在研究活動中增加重組蛋白的使用
    • 擴大藥物研發和精準醫學的研究活動
    • 生技藥品和生物相似藥的採用增加
  • 市場抑制因素分析
    • 有關蛋白質生產的法規和安全問題
    • 缺乏熟練的人員和專業知識
  • 營商環境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第4章 按產品業務分析

  • 研究級蛋白質市場：產品變異分析
  • 細胞激素和生長因子
    • 干擾素 (IFN)
    • 白細胞介素 (IL)
    • 其他
  • 抗體
  • 免疫檢查點蛋白
  • 病毒抗原
  • 酵素
    • 激酶
    • 代謝酵素
    • 其他
  • 重組調節蛋白
  • 荷爾蒙
  • 其他

第5章 宿主細胞的業務分析

  • 研究級蛋白質市場：宿主細胞變異分析
  • 哺乳動物細胞
  • 細菌細胞
  • 酵母和真菌
  • 昆蟲細胞
  • 其他

第6章 最終用途的業務分析

  • 研究級蛋白質市場：最終用途變化分析
  • 製藥和生物技術公司
  • 學術研究所
  • 其他

第7章 區域業務分析

  • 區域市場簡介
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率/地位分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc.
    • Abcam Plc
    • Miltenyi Biotec
    • GenScript
    • Bio-Techne
    • Proteintech Group, Inc.
    • ACROBiosystems
    • Sino Biological, Inc.
    • Prospec-Tany Technogene Ltd.
    • New England Biolabs
Product Code: GVR-4-68040-130-6

Research-grade Proteins Market Growth & Trends:

The global research-grade proteins market size is estimated to reach USD 2.69 billion by 2030, growing at a CAGR of 15.53% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.'s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights:

  • Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.36% in 2022 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
  • Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2022. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
  • Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.35% in 2022. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
  • Based on region, North America dominated the market with a revenue share of 44.86% in 2022. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Host Cell Segment
    • 1.2.3. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Research-grade Proteins Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing use of recombinant proteins in research activities
    • 3.3.2. Growing research activities for drug discovery and precision medicine
    • 3.3.3. Rising adoption of biologics & biosimilars
  • 3.4. Market Restraint Analysis
    • 3.4.1. Regulatory and safety concerns regarding protein production
    • 3.4.2. Dearth of skilled personnel and expertise
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Research-grade Proteins Market: Product Movement Analysis
  • 4.2. Cytokines & Growth Factors
    • 4.2.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.2.2. Interferons (IFNs)
      • 4.2.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
    • 4.2.3. Interleukins (ILs)
      • 4.2.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Antibodies
    • 4.3.1. Antibodies, 2018 - 2030 (USD Million)
  • 4.4. Immune Checkpoint Proteins
    • 4.4.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
  • 4.5. Virus Antigens
    • 4.5.1. Virus Antigens Market, 2018 - 2030 (USD Million)
  • 4.6. Enzymes
    • 4.6.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.6.2. Kinases
      • 4.6.2.1. Kinases Market, 2018 - 2030 (USD Million)
    • 4.6.3. Metabolic Enzymes
      • 4.6.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.7. Recombinant Regulatory Proteins
    • 4.7.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
  • 4.8. Hormones
    • 4.8.1. Hormones Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

  • 5.1. Research-grade Proteins Market: Host Cell Movement Analysis
  • 5.2. Mammalian Cells
    • 5.2.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
  • 5.3. Bacterial Cells
    • 5.3.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 5.4. Yeast & Fungi
    • 5.4.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 5.5. Insect Cells
    • 5.5.1. Insect Cells Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Research-grade Proteins Market: End-use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Scenario
      • 7.2.2.4. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Scenario
      • 7.2.3.4. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Scenario
      • 7.3.5.4. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Scenario
      • 7.3.6.4. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Scenario
      • 7.3.7.4. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Scenario
      • 7.3.8.4. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Scenario
      • 7.3.9.4. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Mexico Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Abcam Plc
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Miltenyi Biotec
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Product Benchmarking
      • 8.4.3.3. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Techne
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Proteintech Group, Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Product Benchmarking
      • 8.4.6.3. Strategic Initiatives
    • 8.4.7. ACROBiosystems
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Sino Biological, Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. Prospec-Tany Technogene Ltd.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Product Benchmarking
      • 8.4.10.3. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 6 North America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 9 U.S research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 12 Canada research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 16 Europe research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 19 UK research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 22 Germany research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 24 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 25 France research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 27 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 28 Italy research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 30 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 31 Spain research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 33 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 34 Denmark research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 36 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 37 Sweden research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 39 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 40 Norway research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 46 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 47 China research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 49 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 50 Japan research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 52 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 53 India research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 55 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 56 South Korea research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 58 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 59 Australia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 61 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 62 Thailand research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 64 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 65 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 66 Latin America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 68 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 69 Brazil research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 71 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 72 Mexico research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 75 Argentina research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 82 South Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 88 UAE research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 91 Kuwait research-grade proteins market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global research-grade proteins market- Key market driver analysis
  • Fig. 7 Global research-grade proteins market - Key market restraint analysis
  • Fig. 8 Global research-grade proteins market - Porter's analysis
  • Fig. 9 Global research-grade proteins market - PESTEL analysis
  • Fig. 10 Global research-grade proteins market: Product outlook key takeaways
  • Fig. 11 Global research-grade proteins market: Product movement analysis
  • Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
  • Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
  • Fig. 27 Global research-grade proteins market: Host cells movement analysis
  • Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Global research-grade proteins market: End-use outlook key takeaways
  • Fig. 34 Global research-grade proteins market: End-use movement analysis
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
  • Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Global research-grade proteins market: Regional movement analysis
  • Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 44 UK research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 46 France research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 54 China research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 55 India research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 68 Strategy framework